4//SEC Filing
Collins Helen Louise 4
Accession 0001415889-25-003509
CIK 0001672619other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:25 PM ET
Size
5.6 KB
Accession
0001415889-25-003509
Insider Transaction Report
Form 4
Collins Helen Louise
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 totalExercise: $22.47Exp: 2035-02-06→ Common Stock (171,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option will vest on February 6, 2026 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001701247
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:25 PM ET
- Size
- 5.6 KB